Literature DB >> 16336552

Commentary--improving diabetes care by combating clinical inertia.

Patrick J O'Connor1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336552      PMCID: PMC1361230          DOI: 10.1111/j.1475-6773.2005.00437.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


× No keyword cloud information.
  23 in total

1.  The public release of performance data: what do we expect to gain? A review of the evidence.

Authors:  M N Marshall; P G Shekelle; S Leatherman; R H Brook
Journal:  JAMA       Date:  2000-04-12       Impact factor: 56.272

Review 2.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

Review 3.  Electronic medical records and diabetes care improvement: are we waiting for Godot?

Authors:  Patrick J O'Connor
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

4.  Improving diabetes care in a large health care system: an enhanced primary care approach.

Authors:  J Sperl-Hillen; P J O'Connor; R R Carlson; T B Lawson; C Halstenson; T Crowson; J Wuorenma
Journal:  Jt Comm J Qual Improv       Date:  2000-11

5.  Setting evidence-based priorities for diabetes care improvement.

Authors:  Patrick J O'Connor
Journal:  Int J Qual Health Care       Date:  2003-08       Impact factor: 2.038

6.  The impact of planned care and a diabetes electronic management system on community-based diabetes care: the Mayo Health System Diabetes Translation Project.

Authors:  Victor M Montori; Sean F Dinneen; Colum A Gorman; Bruce R Zimmerman; Robert A Rizza; Susan S Bjornsen; Erin M Green; Sandra C Bryant; Steven A Smith
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

7.  Developing a quality measure for clinical inertia in diabetes care.

Authors:  Dan R Berlowitz; Arlene S Ash; Mark Glickman; Robert H Friedman; Leonard M Pogach; Audrey L Nelson; Ashley T Wong
Journal:  Health Serv Res       Date:  2005-12       Impact factor: 3.402

8.  A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project.

Authors:  James B Meigs; Enrico Cagliero; Anil Dubey; Patricia Murphy-Sheehy; Catharyn Gildesgame; Henry Chueh; Michael J Barry; Daniel E Singer; David M Nathan
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

9.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

10.  Hypertension management in patients with diabetes: the need for more aggressive therapy.

Authors:  Dan R Berlowitz; Arlene S Ash; Elaine C Hickey; Mark Glickman; Robert Friedman; Boris Kader
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

View more
  12 in total

1.  Care quality and implementation of the chronic care model: a quantitative study.

Authors:  Leif I Solberg; A Lauren Crain; Joann M Sperl-Hillen; Mary C Hroscikoski; Karen I Engebretson; Patrick J O'Connor
Journal:  Ann Fam Med       Date:  2006 Jul-Aug       Impact factor: 5.166

2.  Simulated physician learning intervention to improve safety and quality of diabetes care: a randomized trial.

Authors:  Patrick J O'Connor; Joann M Sperl-Hillen; Paul E Johnson; William A Rush; Stephen E Asche; Pradyumina Dutta; George R Biltz
Journal:  Diabetes Care       Date:  2009-01-26       Impact factor: 19.112

3.  Implementation of a chronic illness model for diabetes care in a family medicine residency program.

Authors:  Grace Chen Yu; Robin Beresford
Journal:  J Gen Intern Med       Date:  2010-09       Impact factor: 5.128

4.  Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care.

Authors:  Monika M Safford; Richard Shewchuk; Haiyan Qu; Jessica H Williams; Carlos A Estrada; Fernando Ovalle; Jeroan J Allison
Journal:  J Gen Intern Med       Date:  2007-10-24       Impact factor: 5.128

5.  Multiple uncontrolled conditions and blood pressure medication intensification: an observational study.

Authors:  Amanda H Salanitro; Ellen Funkhouser; Bonita S Agee; Jeroan J Allison; Jewell H Halanych; Thomas K Houston; Mark S Litaker; Deborah A Levine; Monika M Safford
Journal:  Implement Sci       Date:  2010-07-19       Impact factor: 7.327

6.  Treatment intensification and blood glucose control among hospitalized diabetic patients.

Authors:  Michael E Matheny; Maria Shubina; Zebadiah M Kimmel; Merri L Pendergrass; Alexander Turchin
Journal:  J Gen Intern Med       Date:  2007-12-08       Impact factor: 5.128

7.  Comparing methods of measuring treatment intensification in hypertension care.

Authors:  Adam J Rose; Dan R Berlowitz; Meredith Manze; Michelle B Orner; Nancy R Kressin
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-06-16

8.  Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.

Authors:  Salim S Virani; Kevin F Kennedy; Julia M Akeroyd; Pamela B Morris; Vera A Bittner; Frederick A Masoudi; Neil J Stone; Laura A Petersen; Christie M Ballantyne
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-05

9.  Sustained hyperglycemia among patients with diabetes: what matters when action is needed?

Authors:  Jennifer E Lafata; Elizabeth A Dobie; George W Divine; Marianne E Ulcickas Yood; Bruce D McCarthy
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 19.112

10.  Improving organisational systems for diabetes care in Australian Indigenous communities.

Authors:  Ross Bailie; Damin Si; Michelle Dowden; Lynette O'Donoghue; Christine Connors; Gary Robinson; Joan Cunningham; Tarun Weeramanthri
Journal:  BMC Health Serv Res       Date:  2007-05-06       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.